These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30017261)

  • 1. Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapy.
    McGrory CL; Ryan KM; Kolshus E; Finnegan M; McLoughlin DM
    Eur Neuropsychopharmacol; 2018 Sep; 28(9):1015-1023. PubMed ID: 30017261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood E2F1 mRNA in depression and following electroconvulsive therapy.
    McGrory CL; Ryan KM; Kolshus E; McLoughlin DM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():380-385. PubMed ID: 30365982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression.
    Kolshus E; Ryan KM; Blackshields G; Smyth P; Sheils O; McLoughlin DM
    Acta Psychiatr Scand; 2017 Dec; 136(6):594-606. PubMed ID: 28975998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy.
    Ryan KM; McLoughlin DM
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):839-848. PubMed ID: 29968119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood GILZ mRNA levels in depression and following electroconvulsive therapy.
    Ryan KM; McLoughlin DM
    Psychoneuroendocrinology; 2019 Mar; 101():304-310. PubMed ID: 30602137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT.
    Ryan KM; McLoughlin DM
    Int J Neuropsychopharmacol; 2023 Feb; 26(2):107-115. PubMed ID: 36472850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study.
    Ryan KM; Glaviano A; O'Donovan SM; Kolshus E; Dunne R; Kavanagh A; Jelovac A; Noone M; Tucker GM; Dunn MJ; McLoughlin DM
    Transl Psychiatry; 2017 Mar; 7(3):e1073. PubMed ID: 28350398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBMC telomerase activity in depression and the response to electroconvulsive therapy.
    Ryan KM; Finnegan M; Harkin A; McLoughlin DM
    Eur Arch Psychiatry Clin Neurosci; 2021 Oct; 271(7):1297-1307. PubMed ID: 34268617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
    Freire TF; Fleck MP; da Rocha NS
    Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy.
    Olajossy M; Olajossy B; Wnuk S; Potembska E; Urbańska E
    Psychiatr Pol; 2017 Jun; 51(3):455-468. PubMed ID: 28866716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review and Meta-Analysis of Brief Versus Ultrabrief Right Unilateral Electroconvulsive Therapy for Depression.
    Tor PC; Bautovich A; Wang MJ; Martin D; Harvey SB; Loo C
    J Clin Psychiatry; 2015 Sep; 76(9):e1092-8. PubMed ID: 26213985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
    Ryan KM; Dunne R; McLoughlin DM
    Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression severity in electroconvulsive therapy (ECT) versus pharmacotherapy trials.
    Kellner CH; Kaicher DC; Banerjee H; Knapp RG; Shapiro RJ; Briggs MC; Pasculli RM; Popeo DM; Ahle GM; Liebman LS
    J ECT; 2015 Mar; 31(1):31-3. PubMed ID: 24839981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Preliminary Observation of Increased Glial Cell Line-Derived Neurotrophic Factor in Manic Switch due to Electroconvulsive Treatment in Depressive Patients.
    Tunca Z; Bayn M; Alkn T; Özerdem A; Resmi H; Akan P
    J ECT; 2015 Sep; 31(3):167-72. PubMed ID: 25354171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal and temporal cortical functional recovery after electroconvulsive therapy for depression: A longitudinal functional near-infrared spectroscopy study.
    Hirano J; Takamiya A; Yamagata B; Hotta S; Miyasaka Y; Pu S; Iwanami A; Uchida H; Mimura M
    J Psychiatr Res; 2017 Aug; 91():26-35. PubMed ID: 28292650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of sirtuin-1 in patients with cerebrovascular stroke.
    Esmayel IM; Hussein S; Gohar EA; Ebian HF; Mousa MM
    Neurol Sci; 2021 Sep; 42(9):3843-3850. PubMed ID: 33507417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine and glutathione levels in plasma before and after ECT treatment.
    Samuelsson M; Gerdin G; Ollinger K; Vrethem M
    Psychiatry Res; 2012 Jun; 198(1):53-7. PubMed ID: 22453189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of depressed patients' expectations prior to electroconvulsive therapy on its effectiveness and tolerability (Exp-ECT): a prospective study.
    Krech L; Belz M; Besse M; Methfessel I; Wedekind D; Zilles D
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):809-817. PubMed ID: 28940099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1: The Value of Functional Outcome, Stroke-Related Dementia, Anxiety, and Depression in Patients with Acute Ischemic Stroke.
    Liang X; Liu Y; Jia S; Xu X; Dong M; Wei Y
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):205-212. PubMed ID: 30361109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.